Joanna Iłżecka

943 total citations
68 papers, 716 citations indexed

About

Joanna Iłżecka is a scholar working on Neurology, Molecular Biology and Physiology. According to data from OpenAlex, Joanna Iłżecka has authored 68 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Neurology, 18 papers in Molecular Biology and 11 papers in Physiology. Recurrent topics in Joanna Iłżecka's work include Amyotrophic Lateral Sclerosis Research (32 papers), Alzheimer's disease research and treatments (10 papers) and Parkinson's Disease Mechanisms and Treatments (9 papers). Joanna Iłżecka is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (32 papers), Alzheimer's disease research and treatments (10 papers) and Parkinson's Disease Mechanisms and Treatments (9 papers). Joanna Iłżecka collaborates with scholars based in Poland and United States. Joanna Iłżecka's co-authors include Z Stelmasiak, Zbigniew Stelmasiak, B Dobosz, Tomasz Kocki, Waldemar A. Turski, Marek Iłżecki, Janusz Solski, Tomasz Zubilewicz, Stanisław Przywara and Piotr Terlecki and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cytokine and Amino Acids.

In The Last Decade

Joanna Iłżecka

61 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joanna Iłżecka Poland	15	391	229	170	128	121	68	716
Gabriele Almer Austria	8	438 1.1×	242 1.1×	167 1.0×	194 1.5×	113 0.9×	9	759
Beatrice Nefussy Israel	15	489 1.3×	160 0.7×	273 1.6×	100 0.8×	82 0.7×	23	640
Eveliina Pollari Finland	10	220 0.6×	204 0.9×	106 0.6×	137 1.1×	103 0.9×	13	551
Anna Martínez‐Muriana Spain	12	205 0.5×	228 1.0×	107 0.6×	289 2.3×	154 1.3×	15	737
Jinseok Park South Korea	15	401 1.0×	270 1.2×	368 2.2×	139 1.1×	95 0.8×	48	834
Virginia Le Verche United States	8	248 0.6×	274 1.2×	154 0.9×	124 1.0×	105 0.9×	9	562
I Niebrój-Dobosz Poland	16	288 0.7×	318 1.4×	169 1.0×	82 0.6×	119 1.0×	62	696
Javier H. Jara United States	14	434 1.1×	249 1.1×	271 1.6×	140 1.1×	106 0.9×	15	677
Diana G. Hernandez‐Ontiveros United States	10	448 1.1×	291 1.3×	167 1.0×	288 2.3×	109 0.9×	10	876
Masamitsu Takatama Japan	18	722 1.8×	364 1.6×	200 1.2×	256 2.0×	402 3.3×	75	1.3k

Countries citing papers authored by Joanna Iłżecka

Since Specialization

Citations

This map shows the geographic impact of Joanna Iłżecka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna Iłżecka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna Iłżecka more than expected).

Fields of papers citing papers by Joanna Iłżecka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna Iłżecka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna Iłżecka. The network helps show where Joanna Iłżecka may publish in the future.

Co-authorship network of co-authors of Joanna Iłżecka

This figure shows the co-authorship network connecting the top 25 collaborators of Joanna Iłżecka. A scholar is included among the top collaborators of Joanna Iłżecka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna Iłżecka. Joanna Iłżecka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Iłżecka, Joanna. (2019). Primary lateral sclerosis – a literature review. 19(4). 162–167. 1 indexed citations

Iłżecka, Joanna, et al.. (2016). NON-SURGICAL AND SURGICAL TREATMENT OF LUMBAR DEGENERATIVE DISC DISEASE IN THE COURSE OF PERIPHERAL NEUROPATHY. Health Problems of Civilization. 9(3). 24–30. 1 indexed citations

Iłżecki, Marek, Stanisław Przywara, Joanna Iłżecka, et al.. (2016). Serum glial fibrillary acidic protein as a marker of brain damage in patients after carotid endarterectomy. 22(1). 1–4. 2 indexed citations

Iłżecka, Joanna, et al.. (2014). Effect of intervertebral disc disease on scoliosis in the lumbar spine. Current Issues in Pharmacy and Medical Sciences. 27(3). 155–158. 1 indexed citations

Wdowiak, Artur, et al.. (2013). Knowledge of factors predisposing to the occurrence of cerebral palsy among pregnant women. Journal of Pre-Clinical and Clinical Research. 6(2). 126–130. 2 indexed citations

Iłżecka, Joanna, et al.. (2012). Częstość występowania naczyniowego uszkodzenia mózgu w populacji powiatu ostrowieckiego. Medycyna Ogólna i Nauki o Zdrowiu. 18(2). 77–83. 2 indexed citations

Iłżecka, Joanna. (2012). Mechanizmy patogenetyczne stwardnienia bocznego zanikowego. SHILAP Revista de lepidopterología. 3 indexed citations

Iłżecka, Joanna. (2012). Serum soluble OX40 in patients with amyotrophic lateral sclerosis.. PubMed. 51(1). 3–7. 6 indexed citations

Iłżecka, Joanna. (2011). EMMPRIN levels in serum of patients with amyotrophic lateral sclerosis. Acta Neurologica Scandinavica. 124(6). 424–428. 5 indexed citations

10.

Iłżecka, Joanna. (2011). Serum caspase-9 levels are increased in patients with amyotrophic lateral sclerosis. Neurological Sciences. 33(4). 825–829. 18 indexed citations

11.

Iłżecka, Joanna, et al.. (2010). Back pain – causes and procedure. Medycyna Ogólna i Nauki o Zdrowiu. 16(3). 315–322.

12.

Iłżecka, Joanna, et al.. (2010). Bóle kręgosłupa – przyczyny, postępowanie. Medycyna Ogólna i Nauki o Zdrowiu. 16(3). 315–322.

13.

Iłżecka, Joanna. (2008). Serum-soluble receptor for advanced glycation end product levels in patients with amyotrophic lateral sclerosis. Acta Neurologica Scandinavica. 120(2). 119–122. 37 indexed citations

14.

Iłżecka, Joanna. (2007). Decreased serum-soluble TRAIL levels in patients with amyotrophic lateral sclerosis. Acta Neurologica Scandinavica. 117(5). 343–346. 8 indexed citations

15.

Iłżecka, Joanna. (2004). Decreased cerebrospinal fluid cGMP levels in patients with amyotrophic lateral sclerosis. Journal of Neural Transmission. 111(2). 167–172. 6 indexed citations

16.

Iłżecka, Joanna. (2004). Cerebrospinal fluid vascular endothelial growth factor in patients with amyotrophic lateral sclerosis. Clinical Neurology and Neurosurgery. 106(4). 289–293. 40 indexed citations

17.

Iłżecka, Joanna. (2004). Increased serum CNTF level in patients with amyotrophic lateral sclerosis.. PubMed. 14(3). 192–4. 13 indexed citations

18.

Iłżecka, Joanna. (2003). Prostaglandin E2 is increased in amyotrophic lateral sclerosis patients. Acta Neurologica Scandinavica. 108(2). 125–129. 60 indexed citations

19.

Iłżecka, Joanna, Zbigniew Stelmasiak, & B Dobosz. (2002). TRANSFORMING GROWTH FACTOR-BETA 1 (TGF-BETA 1) IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS. Cytokine. 20(5). 239–243. 68 indexed citations

20.

Iłżecka, Joanna, et al.. (1996). Cerebral strokes immunopathology.. PubMed. 51. 103–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact